Molecular Data Inc. (MKDTY)
 OTCMKTS  · Delayed Price · Currency is USD  
0.0001
 0.00 (0.00%)
  At close: Oct 28, 2025
Molecular Data Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
 Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | 
|---|---|---|---|---|---|---|
| Period Ending | Jun '21 Jun 30, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | 
| Cash & Equivalents | 13.22 | 11.31 | 15.16 | 6.48 | 38.52 | - | 
| Short-Term Investments | 336.04 | 336.04 | - | - | - | - | 
| Cash & Short-Term Investments | 349.25 | 347.35 | 15.16 | 6.48 | 38.52 | - | 
| Cash Growth | -14.79% | 2191.82% | 134.00% | -83.19% | - | - | 
| Accounts Receivable | 87.42 | 82.55 | 207.13 | 55.62 | 97.53 | - | 
| Other Receivables | 3.97 | 9.49 | 4.02 | 6.64 | 3.69 | - | 
| Receivables | 91.39 | 92.04 | 211.15 | 62.26 | 101.22 | - | 
| Inventory | 4.28 | 2.82 | 4.35 | 7.26 | 19.2 | - | 
| Prepaid Expenses | - | 0.51 | 21.44 | 1.65 | 1.06 | - | 
| Restricted Cash | 0.28 | 0.28 | 42.52 | - | 67.5 | - | 
| Other Current Assets | 298.7 | 220.18 | 192.22 | 290.06 | 148.96 | - | 
| Total Current Assets | 743.89 | 663.19 | 486.83 | 367.7 | 376.46 | - | 
| Property, Plant & Equipment | 4.63 | 4.92 | 4.33 | 1.76 | 2.65 | - | 
| Long-Term Investments | 3.75 | 0.35 | - | - | 0.6 | - | 
| Other Intangible Assets | 0.25 | 0.54 | 1.56 | 2.13 | 1.44 | - | 
| Long-Term Deferred Tax Assets | 10.5 | 15.83 | - | - | - | - | 
| Total Assets | 763.02 | 684.82 | 492.72 | 371.6 | 381.15 | - | 
| Accounts Payable | 322.43 | 315.73 | 304.38 | 49.32 | 67.01 | - | 
| Accrued Expenses | 152.49 | 91.96 | 86.36 | 23.94 | 41.33 | - | 
| Short-Term Debt | 80.8 | 49.85 | 13.75 | 0.08 | 138.57 | - | 
| Current Portion of Long-Term Debt | - | 109.35 | 143.96 | 26.01 | - | - | 
| Current Portion of Leases | 1.54 | 1.54 | 3.08 | - | - | - | 
| Current Income Taxes Payable | - | - | 0.39 | - | - | - | 
| Current Unearned Revenue | 68.69 | 81.64 | 107.18 | 153.47 | 44.84 | - | 
| Other Current Liabilities | 175.86 | 42.55 | 16.66 | 2.6 | 8.1 | - | 
| Total Current Liabilities | 801.82 | 692.61 | 675.76 | 255.42 | 299.86 | - | 
| Long-Term Debt | - | - | 31.62 | 177.78 | 75 | - | 
| Long-Term Leases | 19.71 | 19.71 | - | - | - | - | 
| Long-Term Unearned Revenue | - | - | - | 0.03 | 0.39 | - | 
| Other Long-Term Liabilities | 0.34 | 0.34 | 1.83 | - | - | - | 
| Total Liabilities | 821.87 | 712.66 | 709.21 | 433.22 | 375.25 | - | 
| Common Stock | 0.14 | 0.11 | 0.1 | 0.1 | 0.1 | - | 
| Additional Paid-In Capital | 1,075 | 1,075 | 537.62 | 498.63 | 311.51 | - | 
| Retained Earnings | -1,113 | -1,082 | -753.9 | -560.35 | -305.71 | - | 
| Comprehensive Income & Other | -21.19 | -21.19 | -0.32 | - | - | - | 
| Total Common Equity | -59.2 | -27.93 | -216.5 | -61.63 | 5.9 | - | 
| Minority Interest | 0.34 | 0.09 | - | - | - | - | 
| Shareholders' Equity | -58.86 | -27.84 | -216.5 | -61.63 | 5.9 | - | 
| Total Liabilities & Equity | 763.02 | 684.82 | 492.72 | 371.6 | 381.15 | - | 
| Total Debt | 102.05 | 180.45 | 192.41 | 203.87 | 213.57 | - | 
| Net Cash (Debt) | 247.2 | 166.9 | -177.25 | -197.39 | -175.05 | - | 
| Net Cash Per Share | 24.96 | 21.57 | -25.68 | -28.60 | -25.36 | - | 
| Filing Date Shares Outstanding | 9.9 | 8.66 | 6.9 | 6.9 | 6.9 | 6.9 | 
| Total Common Shares Outstanding | 9.9 | 8.66 | 6.9 | 6.9 | 6.9 | 6.9 | 
| Working Capital | -57.93 | -29.42 | -188.93 | 112.29 | 76.6 | - | 
| Book Value Per Share | -5.98 | -3.22 | -31.36 | -8.93 | 0.85 | - | 
| Tangible Book Value | -59.44 | -28.46 | -218.06 | -63.76 | 4.46 | - | 
| Tangible Book Value Per Share | -6.00 | -3.29 | -31.59 | -9.24 | 0.65 | - | 
| Machinery | - | 4.14 | 4.13 | 3.69 | 3.25 | - | 
| Leasehold Improvements | - | 0.8 | 2.7 | 2.28 | 2.24 | - | 
Updated Oct 1, 2021. Source: S&P Global Market Intelligence. Standard template. Financial Sources.